QMED NORWAY AS
Operating
Levere tjenester i forbindelse med gjennomføring av forsøk med
medisinsk utstyr eller legemidler, herunder tjenester i forbindelse
med planlegging og styring av klinisk forskning og utviklingsaktivitet
utført av bioteknologiske og farmasøytiske selskaper, samt det som
naturlig står i forbindelse med dette.
Organization
- CEO
- HQ
- Chairman of the board
- HQ
- Years since formation
- 3 years
- since Feb 7, 2023
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 5
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 1,283,258
- NOK
- Annual total result 2025
- 25,510
- NOK
- Total equity 2025
- 203,806
- NOK
Last update: May 16, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
HQ | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
HQ | Chairman | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Last update: Dec 19, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 5 | 100 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 1,283,258 | 1,398,355 | 1,907,332 | 0 |
Annual Total Result | 25,510 | -160,262 | 1,403,152 | -1,107,797 |
Total assets | 972,698 | 1,134,702 | 816,284 | 50,000 |
Total liabilities | 768,892 | 956,405 | 477,725 | 1,114,593 |
Total equity | 203,806 | 178,296 | 338,558 | -1,064,594 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 1,283,258 | 1,398,355 | 1,907,332 | 0 |
Total operating costs | 1,257,780 | 1,547,277 | 480,298 | 1,107,752 |
Operating result | 25,478 | -148,922 | 1,427,034 | -1,107,752 |
Financial income/costs | 32 | -11,341 | 57,506 | -44 |
Profit before tax | 25,510 | -160,262 | 1,484,540 | -1,107,797 |
Total tax & extraordinary income/cost | 0 | 0 | 81,388 | 0 |
Annual Total Result | 25,510 | -160,262 | 1,403,152 | -1,107,797 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 972,698 | 1,134,702 | 816,284 | 50,000 |
Total assets | 972,698 | 1,134,702 | 816,284 | 50,000 |
Short term debt | 768,892 | 956,405 | 477,725 | 1,114,593 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 768,892 | 956,405 | 477,725 | 1,114,593 |
Contributed capital | 43,203 | 43,203 | 43,203 | 43,203 |
Retained earnings | 160,603 | 135,093 | 295,355 | -1,107,797 |
Total equity | 203,806 | 178,296 | 338,558 | -1,064,594 |
Total equity and liabilities | 972,698 | 1,134,701 | 816,284 | 49,999 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification